TRULIEVE CANNABIS CORP

TRLVNYSE

🏆 #1802 by market capEarnings Nov 6US Equity

$327.42▼ $22.20 (−6.78%)

Simulated price

1h—

24h▼ 6.8%

7d—

14d—

30d—

1y—

🏦Market Cap

$1.58B

Small Cap

📈Revenue Growth (YoY)

+0.0%

Slowing

📊Gross Margin

54.6%

Healthy

💵FCF Margin

20.3%

Strong

⚖️P/S Ratio

1.7x

Cheap

Otter Score

Weak

No chart data available for TRLV.

Trading Snapshot

Day Range: $322.74 – $332.53
52-Week Range: $4.62 – $13.28
Volume: $4.03B
Avg Volume: $5.12B
Shares Outstanding: 169.9M
Next Earnings: Oct 13, 2026

Fundamentals Snapshot

Annual Revenue: $1.18B
Last Q Revenue: $271M
P/E Ratio: -27.1
P/S Ratio: 1.7x
EPS (TTM): $-0.42
Dividend Yield: 0.00%

Why Investors Own TRLV

✓High-growth profile — revenue up +14.6% YoY with expanding US Equity exposure.
✓Healthy economics — 65% gross margin and 7% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$1.18B▲ +15.5% YoY

Gross Margin (TTM)

64.7%▲ +2.7% YoY

Operating Income (TTM)

$424M▲ +15.5% YoY

Free Cash Flow (TTM)

$80M▲ +15.5% YoY

About TRULIEVE CANNABIS CORP

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

🦦